MetaCap

GlucoTrack Insider Trades

NASDAQ: GCTKHealth CareMedical/Dental InstrumentsUSD

1.03-0.08 (-7.21%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

GlucoTrack insider activity

No GlucoTrack insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Balo Andrew K (Director) reporting a transaction in 1,285 shares on Oct 3, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GCTK's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GCTK insider transactions

GlucoTrack insider transactions
DateInsiderTypeSharesValueFiling
Oct 3, 2025Malave LuisDirectorAward463—Form 4
Oct 3, 2025Carter Erin CatherineDirectorAward386—Form 4
Oct 3, 2025Balo Andrew KDirectorAward1,285—Form 4
Jul 11, 2025Malave LuisDirectorAward1,200—Form 4
Jul 11, 2025Carter Erin CatherineDirectorAward1,000—Form 4
Jul 11, 2025Balo Andrew KDirectorAward3,332—Form 4
Mar 26, 2025Fischell RobertDirectorAward1,498—Form 4
Mar 26, 2025Balo Andrew KDirectorAward4,490—Form 4
Mar 26, 2025Danzig AllenDirectorAward1,498—Form 4
Mar 26, 2025Carter Erin CatherineDirectorAward1,896—Form 4
Mar 26, 2025Malave LuisDirectorAward2,076—Form 4
Mar 26, 2025BALLANTYNE JOHNDirectorAward4,126—Form 4
Mar 25, 2025Goode PaulChief Executive Officerother42—Form 4
Mar 25, 2025Malave LuisDirectorAward35—Form 4
Mar 25, 2025Carter Erin CatherineDirectorAward32—Form 4
Mar 25, 2025Balo Andrew KDirectorAward75—Form 4
Mar 12, 2025Goode PaulChief Executive OfficerOption exercise15,435—Form 4
Mar 12, 2025Carter Erin CatherineDirectorOption exercise40,297—Form 4
Mar 12, 2025Malave LuisDirectorOption exercise133,532—Form 4
Mar 12, 2025BALLANTYNE JOHNDirectorOption exercise2,560,553—Form 4
Mar 12, 2025John A. Ballantyne Revocable Living Trust dated 08/01/201710% OwnerOption exercise2,560,553—Form 4
Feb 5, 2025Goode PaulChief Executive Officerother1,500—Form 4
Nov 14, 2024Goode PaulChief Executive OfficerConversion796$24.84KForm 4
Nov 14, 2024Carter Erin CatherineDirectorConversion2,078$64.83KForm 4
Nov 14, 2024Malave LuisDirectorConversion6,886$214.84KForm 4
Nov 14, 2024BALLANTYNE JOHNDirectorother132,036$4.09MForm 4
Nov 14, 2024John A. Ballantyne Revocable Living Trust dated 08/01/201710% Ownerother132,036$4.09MForm 4
Apr 22, 2024SYCOFF DREWDirectorBuy182,540$230.00KForm 4
Apr 8, 2024Fischell RobertDirectorAward229—Form 4
Apr 8, 2024Danzig AllenDirectorAward229—Form 4
Apr 8, 2024Carter Erin CatherineDirectorAward458—Form 4
Apr 8, 2024Malave LuisDirectorAward489—Form 4
Dec 31, 2023Carter Erin CatherineDirectorAward903—Form 4
Dec 31, 2023Malave LuisDirectorAward362—Form 4
Apr 20, 2023Malave LuisDirectorAward121—Form 4
Jan 9, 2023Malave LuisDirectorAward29—Form 4
Oct 4, 2022Danzig AllenDirectorAward44—Form 4
Oct 4, 2022Malave LuisDirectorAward44—Form 4
Jun 30, 2022Malave LuisDirectorAward34—Form 4
Mar 31, 2022Malave LuisDirectorAward25—Form 4
Dec 31, 2021Malave LuisDirectorAward11—Form 4
Sep 30, 2021Malave LuisDirectorAward8—Form 4
Aug 24, 2021Fischell RobertDirectorAward318—Form 4
Mar 20, 2017Seff LeslieDirectorAward3,334—Form 4
Mar 20, 2017BOYDSTON ANGELA STRANDDirectorAward4,445—Form 4
Mar 20, 2017BOYDSTON ANGELA STRANDDirectorAward13,334—Form 4
Mar 11, 2015Gal AvnerChairman and CEOother136,162—Form 4
Mar 11, 2015Malka DavidVice President of Operationsother61,471—Form 4
Mar 11, 2015Cohen ZviDirectorother120,077—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related